Table 6 Postmarketing Reports of Adverse Drug Reactions Blood and Lymphatic System Disorders Leukopenia, neutropenia, thrombocytopenia Immune System Disorders Anaphylaxis; anaphylactic, anaphylactoid and allergic reactions; serum sickness; angioneurotic edema Nervous System Disorders Peripheral neuropathy, paresthesia, hypoesthesia, tremor Eye Disorders Visual disturbances, including vision blurred and diplopia Ear and Labyrinth Disorders Transient or permanent hearing loss Cardiac Disorders Congestive heart failure Respiratory, Thoracic and Mediastinal Disorders Pulmonary edema, dyspnea Gastrointestinal Disorders Pancreatitis, dysgeusia Hepatobiliary Disorders Serious hepatotoxicity including some cases of fatal acute liver failure, hepatitis Skin and Subcutaneous Tissue Disorders Toxic epidermal necrolysis, Stevens Johnson syndrome, acute generalized exanthematous pustulosis, erythema multiforme, exfoliative dermatitis, leukocytoclastic vasculitis, alopecia, photosensitivity, urticaria Musculoskeletal and Connective Tissue Disorders Arthralgia Renal and Urinary Disorders Urinary incontinence, pollakiuria Reproductive System and Breast Disorders Erectile dysfunction General Disorders and Administration Site Conditions Investigations Blood creatine phosphokinase increased
cost of propecia